Victory Capital Management Inc Axonics, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Axonics, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 6,386 shares of AXNX stock, worth $453,278. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,386

Previous 6,497 1.71%

Holding current value

$453,278

Previous $436,000 1.83%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$67.3 - $69.67 $7,470 - $7,733	-111 Reduced 1.71%	6,386 $444,000
Q2 2024 Aug 05, 2024	SELL	$66.47 - $69.65 $9,638 - $10,099	-145 Reduced 2.18%	6,497 $436,000
Q1 2024 May 03, 2024	SELL	$56.67 - $69.36 $6,687 - $8,184	-118 Reduced 1.75%	6,642 $458,000
Q4 2023 Feb 05, 2024	BUY	$49.38 - $63.75 $62,712 - $80,962	1,270 Added 23.13%	6,760 $420,000
Q3 2023 Nov 06, 2023	SELL	$48.64 - $62.51 $8.31 Million - $10.7 Million	-170,798 Reduced 96.89%	5,490 $308,000
Q2 2023 Jul 27, 2023	SELL	$47.99 - $60.21 $8.91 Million - $11.2 Million	-185,730 Reduced 51.3%	176,288 $8.9 Million
Q1 2023 May 02, 2023	BUY	$52.6 - $67.34 $143,072 - $183,164	2,720 Added 0.76%	362,018 $19.8 Million
Q4 2022 Feb 10, 2023	BUY	$59.56 - $76.6 $2,918 - $3,753	49 Added 0.01%	359,298 $22.5 Million
Q4 2022 Feb 09, 2023	SELL	$59.56 - $76.6 $12 Million - $15.4 Million	-200,923 Reduced 35.87%	359,249 $22.5 Million
Q3 2022 Nov 02, 2022	BUY	$57.96 - $78.12 $9.27 Million - $12.5 Million	160,019 Added 39.99%	560,172 $39.5 Million
Q2 2022 Aug 01, 2022	SELL	$39.5 - $64.42 $3.79 Million - $6.18 Million	-95,900 Reduced 19.33%	400,153 $22.7 Million
Q1 2022 May 04, 2022	BUY	$43.74 - $62.76 $3.9 Million - $5.59 Million	89,127 Added 21.9%	496,053 $31 Million
Q4 2021 Feb 07, 2022	SELL	$50.01 - $73.35 $168,783 - $247,556	-3,375 Reduced 0.82%	406,926 $22.8 Million
Q3 2021 Nov 02, 2021	BUY	$59.21 - $78.66 $23.9 Million - $31.8 Million	403,647 Added 6066.23%	410,301 $26.7 Million
Q2 2021 Aug 03, 2021	BUY	$51.39 - $66.9 $44,092 - $57,400	858 Added 14.8%	6,654 $422,000
Q1 2021 May 04, 2021	BUY	$49.14 - $59.89 $55,429 - $67,555	1,128 Added 24.16%	5,796 $347,000
Q4 2020 Feb 01, 2021	BUY	$42.19 - $51.5 $759 - $927	18 Added 0.39%	4,668 $233,000
Q3 2020 Nov 09, 2020	BUY	$35.33 - $51.04 $164,284 - $237,336	4,650 New	4,650 $237,000
Q2 2020 Aug 07, 2020	SELL	$22.91 - $39.83 $90,838 - $157,925	-3,965 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$16.44 - $37.73 $16,735 - $38,409	1,018 Added 34.54%	3,965 $101,000
Q4 2019 Feb 04, 2020	BUY	$19.57 - $28.96 $10,861 - $16,072	555 Added 23.2%	2,947 $86,000
Q3 2019 Nov 12, 2019	BUY	$26.92 - $42.41 $64,392 - $101,444	2,392 New	2,392 $64,000

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Axonics, Inc. Transaction History